Form 8-K - Current report:
SEC Accession No. 0001193125-25-004907
Filing Date
2025-01-13
Accepted
2025-01-13 06:06:08
Documents
29
Period of Report
2025-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d907988d8k.htm   iXBRL 8-K 28210
2 EX-99.1 d907988dex991.htm EX-99.1 19601
3 EX-99.2 d907988dex992.htm EX-99.2 20141
4 EX-99.3 d907988dex993.htm EX-99.3 4102
8 GRAPHIC g907988ex99_1s10g1.jpg GRAPHIC 104622
9 GRAPHIC g907988ex99_1s11g1.jpg GRAPHIC 79789
10 GRAPHIC g907988ex99_1s12g1.jpg GRAPHIC 83591
11 GRAPHIC g907988ex99_1s1g1.jpg GRAPHIC 51095
12 GRAPHIC g907988ex99_1s2g1.jpg GRAPHIC 249738
13 GRAPHIC g907988ex99_1s3g1.jpg GRAPHIC 66937
14 GRAPHIC g907988ex99_1s4g1.jpg GRAPHIC 64906
15 GRAPHIC g907988ex99_1s5g1.jpg GRAPHIC 74408
16 GRAPHIC g907988ex99_1s6g1.jpg GRAPHIC 94749
17 GRAPHIC g907988ex99_1s7g1.jpg GRAPHIC 95006
18 GRAPHIC g907988ex99_1s8g1.jpg GRAPHIC 84283
19 GRAPHIC g907988ex99_1s9g1.jpg GRAPHIC 79238
20 GRAPHIC g907988snap1.jpg GRAPHIC 2369
  Complete submission text file 0001193125-25-004907.txt   1768542

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sage-20250110.xsd EX-101.SCH 2847
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20250110_lab.xml EX-101.LAB 17235
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20250110_pre.xml EX-101.PRE 10810
32 EXTRACTED XBRL INSTANCE DOCUMENT d907988d8k_htm.xml XML 3555
Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 25524639
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)